Home
Langlai Technology

Langlai Technology Market Share Analysis for May 2026

createrna is an innovative drug research and development company in the clinical stage.

Industry: N/A

Domaincreaterna.com

Year Founded--

Employees51 - 200

Annual Revenue--

Langlai Technology

Langlai Technology (including company regionals)

createrna.com

See more website traffic and engagement information

Total visits to Langlai Technology's top domains

Understand Langlai Technology market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

createrna.com--

See more with Sales Intelligence

Avg. visit duration in Langlai Technology's top domains

Analyze Langlai Technology engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

createrna.com--

See more with Sales Intelligence

Avg. pageviews on Langlai Technology's top domains

See how Langlai Technology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

createrna.com--

See more with Sales Intelligence

Langlai Technology top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Langlai Technology

These are the website technologies, by industry, used by Langlai Technology top domains

Conversion & Analytics (1)

CNZZ

Email Services (1)

QQ Mail

Mobile (1)

Meta Viewport

News & Signals from Langlai Technology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLillyasiaventures invests into Createrna.Clinical-stage biopharmaceutical firm Createrna Science & Technology has notched 500 million yuan ($ 69.7 million ) in a Series A financing round led by the life science-focused venture capital firm Lilly Asia Ventures (LAV).

NewsCreaterna hired Wang Yaning as Chief Medical Officer on Sep 1st '21.This is another international high-end medical talent introduced by Createrna Technology after Dr. Wang Yaning, former director of Quantitative Pharmacology Review Room, Clinical Pharmacology Department, Drug Review Research Center of FDA, became the CEO of Createrna Technology in September 2021.